4-(2-(2,8-Dimethyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl)-N,N,2-trimethylbenzamide

Catalog No. :
ACLWNE837
CAS No. :
2578803-19-5
Molecular Formula :
C27H29N5O
Molecular Weight :
439.56

IUPAC Name:4-(2-(2,8-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl)-N,N,2-trimethylbenzamide

4-(2-(2,8-Dimethyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl)-N,N,2-trimethylbenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-(2,8-Dimethyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl)-N,N,2-trimethylbenzamide
IUPAC Name4-(2-(2,8-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl)-N,N,2-trimethylbenzamide
MDL No.0
Molecular FormulaC27H29N5O
Molecular Weight439.56
SMILESO=C(N(C)C)C1=CC=C(C2=CNC3=NC=C(C4=CC5=C(CN(C)CC5)C(C)=C4)N=C32)C=C1C
InChI KeyHXNMNQAPEBXRHV-UHFFFAOYSA-N
SynonymBenzamide, N,N,2-trimethyl-4-[2-(1,2,3,4-tetrahydro-2,8-dimethyl-6-isoquinolinyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-;4-[2-(2,8-Dimethyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-N,N,2-trimethylbenzamide
CAS No.2578803-19-5

Synthetic Route by SureRoute

1. ACLWNE837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLWNE837 route product structure diagram
    ACLWNE8372578803-19-5
Inquiry

2. ACLWNE837 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLWNE837 route product structure diagram
    ACLWNE8372578803-19-5
Inquiry

Comments (0)